admin

BETHESDA, Md., Oct. 14, 2015 /PRNewswire-USNewswire/ — The National Foundation for Cancer Research (NFCR) today announced the expansion of its Scientific Advisory Board. The NFCR Scientific Advisory Board includes Webster Cavenee, PhD, Chair; Frederick W. Alt, PhD; Ruggero De Maria, PhD; Kanaga Sabapathy, PhD; and Peter Vogt, PhD.

The mission of the NFCR Scientific Advisory Board is to provide scientific, strategic, and clinical guidance and direction for NFCR basic science and translational research programs. Directed by Webster Cavenee, PhD, the NFCR Scientific Advisory Board is comprised of leaders in cancer research who have made significant breakthroughs in the diagnosis and treatment of cancer, scientists who are committed to furthering NFCR’s unwavering commitment to funding research that will cure cancer—all types of cancer.

Greetings!

We would like to invite you to a special event to join other industry leaders and peers to celebrate a year of growth within our entrepreneurial ecosystem and the greater Biohealth Capital Region.

Several of the region’s top startup executives will participate in an engaging discussion and share the lessons they have learned along their journeys in building their past and current companies.

Greetings!

We would like to invite you to a special event to join other industry leaders and peers to celebrate a year of growth within our entrepreneurial ecosystem and the greater Biohealth Capital Region.

Several of the region’s top startup executives will participate in an engaging discussion and share the lessons they have learned along their journeys in building their past and current companies.

Headwinds ranging from an expected renewal of political wrangling over the price of prescription drugs to increasing pressure on sales of established treatments have largely, but not entirely, kept pharmaceutical companies from enjoying the increases of their biotech counterparts, as reflected in the share prices of exchange-traded funds (ETFs) consisting of pharma equities.

The Netherlands has officially delivered the new Amsterdam headquarters to the European Medicines Agency (EMA). The new office, located in the Zuidas area of Amsterdam, will enable EMA to continue carrying out their activities by assessing medicines without any interruption. Minister Bruno Bruins (Health, Care and Sports) complimented all parties involved with this special achievement, as the new build was completed within a very short time frame: “It is a beautiful and important achievement that EMA will be able to move in this new building in time as promised. Built at a high pace and in a very short time frame.

Image: https://investinholland.com – from video

Dr. Stacy Fisher, a cardiologist with the University of Maryland Medical System, had a patient with an aortic abnormality. He was not getting enough blood flow through one of the vessels that feed the brain. Because of the narrowing, Fisher recommended surgery to move the vessel where it could get better blood flow. The patient, who …

ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) last Thursday, November 14, conducted its latest Salisbury Award Competition for Entrepreneurial Translational Research. This event featured 16 individual cancer research projects from 15 institutions, selected from among a total of 36 applications. It concluded with an evening ceremony at which finalists were recognized, the winner and runners-up were named and the founding Salisbury family of NFCR was honored.

Image: Representatives of the 16 selected cancer research projects, among 36 applicants, who participated in the Salisbury Award Competition. – https://www.nfcr.org

Configo Health, a company developing artificial intelligence-powered data analytics solutions for pediatric healthcare facilities, launched Nov. 18 with the announcement of Texas Children’s Hospital and Children’s National Hospital as founding investors.

Configo Health extracts administrative data from pediatric hospitals to create a comprehensive dataset of near-real-time benchmarked data. The HIPAA-protected information is available for use by patients, public ratings organizations and pediatric care facilities, which can use the compiled performance data to reduce readmissions and improve outcomes.

The A. James Clark School of Engineering at the University of Maryland has produced remarkable engineers, scientists, life science professionals and entrepreneurs that have shaped the Biohealth Capital Region (BHCR) for well over a century. 2019 marks the Clark School’s 125th anniversary as one of the most important STEM talent pipelines in the region and nation.

Image: https://biobuzz.io